STATEMENTS ON THIS WEBSITE REFER ONLY TO THE ORIGINAL FasciaDerm® Heel Pain Relief System (in the orange package) which is no longer sold. For information regarding FasciaDerm PFTAPE® contact Mueller Sports Medicine or visit MuellerSportsMed.com. PFTAPE® is a trademark of Mueller Sports Medicine. FasciaDerm® is a trademark of Applied BioKinetics LLC.

Home » News & Press

News & Press

Browse through FasciaDerm’s latest press releases, media mentions and other articles.

Download PDF (146kb)

Patented Over-the-Counter Plantar Fasciitis Innovation Accepted to Compete in the U.S. Patent Office’s “Patents for Humanity” Contest

Applied BioKinetics LLC’s (ABK) application to the “Patents for Humanity” contest was accepted to compete in the 2014 U.S. Patent Office’s competition. ABK’s contest application is based on its patented, FasciaDerm® brand heel pain relief system, which is bringing new hope to those suffering from plantar fasciitis.

Houston, TX (PRWEB) December 29, 2014 – “Patents for Humanity” is the United States Patent and Trademark Office (USPTO) awards competition recognizing patent owners and licensees working to improve global health, particularly for the less fortunate. Applied BioKinetics LLC’s (ABK) application to the “Patents for Humanity” program is based on the benefit brought to plantar fasciitis sufferers by its patented, fast acting heel and arch pain relief system.

In the 18 years I have been in the sports medicine retail market, I have never experienced so many outspoken and happy customers!

– Herb Raschka, Senior VP at Mueller Sports Medicine

Plantar fasciitis often produces excruciating pain, which is activity-limiting and often described to feel like an ice pick in the heel, particularly upon first standing in the morning. The effect of plantar fasciitis on a breadwinner be it a professional athlete, convenience store clerk, or caregiver, impacts the entire family.

The ABK patented heel pain treatment system is quickly becoming the choice of athletes and other well informed users seeking a conservative solution. The product based on these patents is the FasciaDerm® PFTape System, which is sold under license by Mueller Sports Medicine (MSM). Priced at around $20 for a package containing seven days worth of applications, this pain relieving system brings treatment within economic reach of many individuals whom would otherwise suffer without effective options. This underserved group often includes the uninsured, working poor and others less fortunate.

The ABK-held patents cover a disposable, and adhesively applied, two-part foot taping system, which is configured for ease of self-application. The material used in this system is an ultra thin and ultra strong microfiber fabric, whose properties can be described as “fascia-like”. These properties and methods of application enable FasciaDerm® to provide direct support to the plantar fascia, essentially providing it a degree of rest. Protecting and supporting the plantar fascia consistently in a near 24/7 manner is key to achieving rapid pain relief. As the plantar fascia is allowed to rest, the body’s need for an inflammatory response decreases and inflammation can then begin to subside. The subsidence of inflammation leads to a reduction in pain. Continued uninterrupted use of the FasciaDerm® heel pain relief system is recommended for a period of days after initial pain relief is achieved. This added treatment time is to allow the plantar fascia to regain strength before subjecting it to heavy loads.

The words humane (i.e. having or showing compassion) and humanitarian (i.e. concerned with or seeking to promote human welfare) apply perfectly to the act of providing relief to those suffering in pain. According to Don Bushby, ABK founder, “FasciaDerm® has brought joy-filled heel pain relief to many who were suffering from plantar fasciitis and loosing hope, while spending themselves poor on less effective alternatives.”

“Patents for Humanity” seeks to recognize innovators regardless of size, from large corporations down to the individual inventor. Applied BioKinetics LLC is a single member LLC founded by engineer and innovator Donald Bushby of Houston, Texas. Don was raised by his grandmother on an Illinois farm and dreamed of inventing since an early age. He is pleased to bring a truly effective, non-invasive, innovative, treatment for heel and arch pain to the market. Mr. Bushby thanks Mueller Sports Medicine for making the FasciaDerm® PFTape System available though a growing number retail locations both in the U.S. and internationally.

Herb Raschka, Senior Vice President at Mueller Sports Medicine, was recently quoted: “The consumer compliments for this unique product are received daily. In the 18 years I have been in the sports medicine retail market, I have never experienced so many outspoken and happy customers!”

The judging of the “Patents for Humanity” contest ends December 31, 2014. The winners will be announced by the USPTO in the first quarter of 2015. See ABK’s accepted application to the “Patents for Humanity” contest at https://p4h.skild.com/skild2/p4h/viewEntryVoting.action.

FasciaDerm® PFTape System is proudly made in the USA.
is covered by one or more of the following U.S. Pat. Nos. 8,814,818 8,216,162 8,414,511 8,834,398 8,834,397 and D691276. The FasciaDerm® PFTape System (TM) is proudly made in the USA.

For more information, contact Don Bushby at DBushby(at)FasciaDerm(dot)com or visit http://www.fastheelpainrelief.com.

Applied BioKinetics LLC is committed to developing innovative, conservative solutions to human ailments through engineering, applied science and practical thinking.

Media Contact:
Don Bushby, CEO and Founder
Applied BioKinetics LLC
1211 Nagle Street
Houston, Texas 77003
DBushby(at)FasciaDerm(dot)com

(713) 474-0856 Cell
(888) 433-5339 Toll Free

http://www.fastheelpainrelief.com
http://www.appliedbiokinetics.com

Download PDF (142kb)

Innovative Plantar Fasciitis Treatment Expedites Heel Pain Recovery

Applied BioKinetics LLC was granted a patent on April 9, 2013 for its doctor-recommended plantar fasciitis heel pain relief system, FasciaDerm®. This new innovation represents a significant advancement in the treatment of plantar fasciitis, decreasing the typical pain recovery period to that of only days.

Houston, TX (PRWEB) April 10, 2013 – Applied BioKinetics LLC has been granted patent # 8414511 for its heel pain treatment technology, which promises to significantly reduce pain recovery time. Plantar fasciitis is a painful inflammation of the tough connective tissue – the plantar fascia – which runs along the bottom of the foot. This condition is described to feel like “an ice-pick in the heel,” especially during the first steps upon waking or after other prolonged periods of rest. Plantar fasciitis is the result of small tears in the fascia, generally caused by excessive or repetitive stress on the fascia. Every year, millions of individuals are afflicted with this painful condition, and recovery usually takes several months despite the various treatments available.

There has been a long-standing need for non-invasive plantar fasciitis treatment which provides fast pain relief, and that does not inconvenience daily life

– Donald Bushby, Founder, Applied BioKinetics

FasciaDerm® was developed specifically to manage stress in the plantar fascia, by Donald Bushby, an engineer who recognized at once that conventional devices which simply sit beneath the foot can, at best, provide a meaningful level of stress reduction only during a portion of the walking cycle. These devices fall short in reducing plantar stress during the critical “heel lift” or “propulsion” phase. Protecting the fascia from excessive stress through the entire walking cycle is essential to pain recovery and to the prevention of immediate re-injury. The product is an ultra-thin, micro-fiber support system, designed to adhere to the foot, to provide direct support to the plantar fascia. It can be comfortably worn all-day, during all active hours, to aid in pain management and recovery. Each FasciaDerm® package contains 6 days’ worth of easy-to-apply treatments for a single foot. Typical users often experience significant pain relief in the first few days of use. Average use during heel pain recovery is the range of 9 – 24 days, making FasciaDerm® a highly cost effective treatment for heel pain.

The remarkably improvement in pain recovery time is due to FasciaDerm’s biomechanically-introspective design, specialized adhesive and materials of construction, which together enable it to durably and effectively support and protect the plantar fascia through all stages of the walking cycle. By acting like an “external fascia”, FasciaDerm® can manage the stress placed on the plantar fascia, immediately setting the right conditions for healing. As inflammation subsides, pain is reduced. It’s important to note that pain relief is a welcome first sign of recovery, but the continued use of FasciaDerm® for a period of days (minimum 6), after pain subsides, is recommended to allow the fascia to strengthen before subjecting it to high levels of stress.

While not typically effective in providing rapid pain relief other treatment aproaches such as: orthotics, supportive footwear, stretching, foot strengthening, weight loss and night-splits can each play a role in minimizing potential for new flare-ups and in extending periods between bouts.

In the Company of Champions…

Developed by Applied BioKinetics LLC (ABK), this technology was briefly introduced to the market in 2009. This product’s effectiveness was demonstrated when samples were sent to a professional football team in October 2009, in response to a news report that their star quarterback was injured and confirmed to be suffering from plantar fasciitis. The medical diagnosis was made on a Monday night, and upon hearing the report, unsolicited samples of the ABK heel pain relief product were express shipped to the team, arriving that Wednesday. A follow-up telephone conversation with the training staff on Friday confirmed the product was received and was being used as a key element in the athlete’s treatment program. To the amazement of the sports and sports media communities, this high-profile quarterback practiced lightly on Friday, and played that Sunday, after missing practice on both Wednesday and Thursday. Reporters, familiar with the long recovery times associated with plantar fasciitis, were taken aback by this prompt and successful return to the field. The quarterback did not specifically give credit to the ABK product, but did report daily pain improvement and generally “feeling good”. On the Monday morning following the game, ABK received a phone call from the team’s trainer, who expressed his gratitude and praised the product’s effectiveness. He then proceeded to place one of the first bulk orders for the product.

This originally introduced product was taken off the market shortly after introduction due to trademark challenges. The company is proud to offer the same effective plantar fasciitis treatment under the FasciaDerm® brand name. According to the company’s founder Donald Bushby, “There has been a long standing need for a non-invasive plantar fasciitis treatment which provides fast pain relief, and that does not inconvenience daily life”.

For more information or to set up an interview, contact Donald Bushby or by phone at 713-474-0856 or Toll Free at 888-433-5339.

Applied BioKinetics LLC is a registered medical device manufacturer committed to developing non-invasive, cost-effective solutions through innovation, engineering and applied science.

Media Contact:

Don Bushby, CEO and Founder

Applied BioKinetics LLC

1211 Nagle Street

Houston, Texas 77003

DBushby(at)FasciaDerm(dot)com

(713) 474-0856 Cell

(888) 433-5339 Toll Free

http://www.fastheelpainrelief.com

http://www.appliedbiokinetics.com

Download PDF (171kb)

New Strides in the Treatment of Heel Pain with FasciaDerm® Foot Pain Relief System

On July 12, 2012 Applied BioKinetics LLC was granted a patent for its breakthrough heel pain relief system FasciaDerm. FasciaDerm offers fast and effective relief for the most common cause of heel pain—Plantar Fasciitis.

Houston, TX (PRWEB) August 2, 2012 – Applied BioKinetics LLC was granted a patent this month for technology associated with its foot pain relief product, FasciaDerm®.
A growing number of podiatrists are embracing FasciaDerm® in their practices as an alternative to cortisone injections and as part of a standard of care for foot pain caused by plantar fasciitis. FasciaDerm® bridges the gap between the initial office examinations to the time of a follow-up visit, after the manufacturing of custom orthotics is complete. Reduced heel pain level improves the patient’s satisfaction with the clinic and eases the transition into orthotics.

The most effective treatment for plantar fasciitis may be bed rest—and the closest thing to bed rest is the use of FasciaDerm.

– Donald Bushby, Founder, Applied BioKinetics

The FasciaDerm® Heel Pain Relief and Recovery System (based on issued Patent No. 8,216,162 and other pending patent applications) is a set of disposable, micro-thin, super strong pre-cut fabric supports designed exclusively for direct adhesive support of the foot, and particularly to the plantar fascia. The system utilizes a two part design which is easy to apply. The proprietary materials and slip resistant adhesive effectively support the foot for up to 24 hours per application. In use, FasciaDerm® is applied in the morning and worn through all load bearing hours of the day. The product is then re-applied each consecutive day during the recovery period. The company recommends a minimum of 6 to12 days of treatment per foot to provide the best opportunity to achieve effective and lasting heel pain relief. Each FasciaDerm® package provides product for six days of treatment (i.e. one treatment cycle) for a single foot. Follow-up care for plantar fasciitis often includes; use of supportive footwear, stretching, orthotics, and periodic use of FasciaDerm® during periods of increased activity.

“The most effective treatment for plantar fasciitis may be bed rest—and the closest thing to bed rest is the use of FasciaDerm,” said Applied BioKinetics founder, Donald Bushby.
Plantar fasciitis (PF), a condition where strong connective tissue which runs along the sole and arches of the foot becomes damaged with micro-tears, is most often indicated by sharp pain in the heel or arch during the first few steps in the morning or after periods of rest. Despite the numerous plantar fasciitis treatment methods and devices available, most cases of plantar fasciitis linger for months. Recovery is often long or evasive due in part to the lack of protection these treatments provide to the fascia during the healing process. Lack of direct support to the plantar fascia can allow newly repaired tissue to easily be re-damaged.

Current PF treatment methods include steroid injections, immobilizing devices (boots or casts), devices to perform night-time stretching and surgery (in extreme cases). Tape based products have also made inroads in PF treatment. However, these common athletic tape or multi-purpose stretch tape products generally lack effectiveness in the rigorous and specialized task of managing stress in the plantar fascia.

PF sufferers often spend hundreds of dollars and many months impaired and in pain trying devices and methods which lack effectiveness. FasciaDerm® is a leap forward in reducing heel pain and arch pain recovery time, and at a retail price of under $30 per treatment cycle, it also reduces the average cost to consumers.

About Applied BioKinetics LLC:

Applied BioKinetics LLC is a registered medical device manufacturer committed to developing non-invasive, cost-effective solutions through innovation and applied science.

Media Contact:

Don Bushby, CEO and Founder

Applied BioKinetics LLC

1211 Nagle Street

Houston, Texas 77003

DBushby(at)FasciaDerm(dot)com

(713) 474-0856 Cell

(888) 433-5339 Toll Free

http://www.fastheelpainrelief.com

http://www.appliedbiokinetics.com

Download PDF (2.9MB)

Competitor Magazine Top Picks

These disposable micro-thin strips wrap around your feet to relieve heel and arch pain caused by plantar fasciitis. The bandage-like strip won’t slip or break down while you’re running and acts like an external ligament, allowing the fascia to rest in order to accelerate recovery.

– Cielestia Calbay,

If there’s one thing that runners know, it’s that the possibility for an overuse injury is always around the corner. Competitor Magazine published a list of its top recommended products for dealing with these aches and pains, and FasciaDerm strips made the list!

Competitor Magazine Top Pick
Read the FasciaDerm Review in Competitor Magazine

Medical Device Innovator Applied BioKinetics LLC, Announces a Breakthrough in the Treatment of Heel Pain Caused by Plantar Fasciitis

Medical device innovator Applied BioKinetics LLC, announces a breakthrough in the treatment of heel pain caused by plantar fasciitis (i.e. heel spur syndrome). Plantar fasciitis is a painful condition where small tears in the tough connective tissue which runs along the bottom of the foot (i.e. the plantar fascia) have occurred, as a result of excessive or repetitive stress. The condition is most often indicated by sharp heel pain during the first few steps in the morning or after periods of rest. Many cases of plantar fasciitis linger for six months or more, despite current treatment methods.

Applied BioKinetics’ flagship product, FasciaDerm® Brand Pain Relief and Recovery Strips, feature a micro-thin, disposable and adhesively applied support layer designed to directly support the foot and manage foot strain, thus allowing the user to remain active. FasciaDerm®‘s advanced materials and adhesive technologies have been optimized specifically for managing stress in the plantar fascia. Managing foot strain through the entire gait cycle, in a consistent manner, improves conditions favorable to natural and lasting recovery from heel pain.

FasciaDerm® is effective in the treatment of acute and chronic plantar fasciitis as an adjunct to custom orthotics.

– Dr. Daryl Caneva, Caneva Foot Clinic

Dr. Daryl Caneva of Caneva Foot Clinic in Joliet, Illinois concluded, “FasciaDerm® is effective in the treatment of acute and chronic plantar fasciitis as an adjunct to custom orthotics.” The clinic reports high end-user satisfaction and has incorporated FasciaDerm(R) into their standard of care.

Whether applied in a clinic setting or self-applied at home, FasciaDerm® is perfect for those who have struggled for weeks or months with other approaches including: night-time stretching devices, plantar taping methods and cortisone injections. FasciaDerm® is often used for foot pain prevention, but when used as directed during a plantar fasciitis flare up, it provides effective foot-pain relief benefits within days of consistent use. Many report lasting pain relief within 1-2 six day treatment cycles with FasciaDerm®. FasciaDerm® is compatible with over the counter arch supports and custom orthotics which are intended to provide long-term correction of foot bio-mechanical issues. FasciaDerm® provides an alternative to cortisone injections and night-splint devices.

About Applied BioKinetics LLC:

Applied BioKinetics LLC is a registered medical device manufacturer committed to developing non-invasive, cost-effective, drug-free solutions through innovation and applied science.

Plantar Fasciitis Symptoms:

In most cases, the pain associated with plantar fasciitis develops gradually and affects just one foot, although it can occur in both feet at the same time. Pain is typically in intense during the first few steps in the morning, or during the first few steps after a period of rest. The pain is best described as feeling like an ice pick in the heel of your foot.

Media Contact:

Sales(at)FasciaDerm(dot)com

(713) 474-0856; (888) 433-5339 toll free

http://www.fastheelpainrelief.com

http://www.appliedbiokinetics.com

Scroll To Top